Immunosuppression and Outcomes in Acute Myeloid Leukemia
F. Ferraro, C. Miller, K. Christensen, N. M. Helton, M. O'Laughlin, C. C. Fronick, R. S. Fulton, J. Kohlschmidt, A.-K. Eisfeld, C. D. Bloomfield, S. M. Ramakrishnan, R. B. Day, L. D. Wartman, G. L. Uy, J. S. Welch, , T. J. Ley
This study identifies immunosuppressive features in AML cells associated with poor outcomes in patients treated with standard chemotherapy.
bioRxiv · Sep 3, 2021 · PreprintCancer Biology